CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$4.17
-0.17 (-3.92%)
▼
5d:
-3.47%
30d:
-22.63%
90d:
+51.64%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
1d
Smart Money Accumulation
None View Scanner →
Strength: 6.9/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CLOV shows positive signals but monitor for confirmation. Market pricing in 4.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: CLOV shows positive signals but monitor for confirmation. Market pricing in 4.5% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $4.17, which is considered oversold relative to its 30-day fair value range of $4.39 to $5.15. From a valuation perspective, the stock is trading at a premium (Forward PE: 41.7) compared to its historical average (36.5). At these levels, the market is pricing in 4.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CLOV is in a strong uptrend. The price is currently testing key support at $4.12. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CLOV is in a strong uptrend. The price is currently testing key support at $4.12. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.39 -
$5.15
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- NEUTRAL: Near Wall St target ($4.58)
- NEUTRAL: Market pricing in 4.5% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$4.39 -
$5.15
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.12
Resistance Level
$4.88
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
41.70
Wall Street Target
$4.58
(+9.9%)
Revenue Growth (YoY)
62.0%
Profit Margin
-2.6%
Valuation Premium vs History
+4.5% premium
PE vs Historical
41.7 vs 36.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.5%
(market-implied from PE analysis)
1-Year Target
$4.36
(+5%)
2-Year Target
$4.55
(+9%)
3-Year Target
$4.76
(+14%)
3-Yr Target (if PE normalizes)
(PE: 42→37)
PE COMPRESSION
$4.17
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 41.7, Growth: 11.1%)
$5.72
(+37%)
Base:
(SPY PE: 20.7, Growth: 11.1%)
$2.84
(-32%)
Bear:
(PE: 17.6, Growth: 11.1%)
$2.42
(-42%)
Share & Embed Analysis
Last updated: August 03, 2026 3:35 AM ET
Data refreshes hourly during market hours. Next update: 4:35 AM
Data refreshes hourly during market hours. Next update: 4:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady Patrick Priest
SELL
175000 shares
2026-03-04
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$114 | 51 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 50 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$343 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 55 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$408 | 54 HOLD |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
